Pfizer Inc. (PFE)
29.88
-0.91
(-2.96%)
USD |
NYSE |
Nov 05, 16:00
29.89
+0.01
(+0.03%)
Pre-Market: 20:00
Pfizer Net Income (TTM) : 4.074B for Sept. 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.074B |
| June 30, 2026 | 4.373B |
| March 31, 2026 | 7.522B |
| December 31, 2025 | 7.786B |
| September 30, 2025 | 9.837B |
| June 30, 2025 | 10.77B |
| March 31, 2025 | 7.896B |
| December 31, 2024 | 8.051B |
| September 30, 2024 | 4.305B |
| June 30, 2024 | -2.564B |
| March 31, 2024 | -255.00M |
| December 31, 2023 | 2.172B |
| September 30, 2023 | 10.51B |
| June 30, 2023 | 21.54B |
| March 31, 2023 | 29.08B |
| December 31, 2022 | 31.40B |
| September 30, 2022 | 29.98B |
| June 30, 2022 | 29.50B |
| March 31, 2022 | 25.45B |
| December 31, 2021 | 22.46B |
| September 30, 2021 | 19.52B |
| June 30, 2021 | 12.26B |
| March 31, 2021 | 9.04B |
| December 31, 2020 | 6.638B |
| September 30, 2020 | 5.677B |
| Date | Value |
|---|---|
| June 30, 2020 | 12.44B |
| March 31, 2020 | 14.89B |
| December 31, 2019 | 16.30B |
| September 30, 2019 | 16.24B |
| June 30, 2019 | 12.67B |
| March 31, 2019 | 11.50B |
| December 31, 2018 | 11.18B |
| September 30, 2018 | 23.85B |
| June 30, 2018 | 22.60B |
| March 31, 2018 | 21.79B |
| December 31, 2017 | 21.35B |
| September 30, 2017 | 9.828B |
| June 30, 2017 | 8.325B |
| March 31, 2017 | 7.31B |
| December 31, 2016 | 7.228B |
| September 30, 2016 | 6.299B |
| June 30, 2016 | 7.074B |
| March 31, 2016 | 7.647B |
| December 31, 2015 | 6.975B |
| September 30, 2015 | 8.398B |
| June 30, 2015 | 8.944B |
| March 31, 2015 | 9.23B |
| December 31, 2014 | 9.119B |
| September 30, 2014 | 10.49B |
| June 30, 2014 | 10.40B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Johnson & Johnson | 16.10B |
| Eli Lilly & Co. | 27.58B |
| Merck & Co., Inc. | 2.449B |
| Bristol Myers Squibb Co. | 9.242B |
| Viatris, Inc. | -- |